Gossamer Bio is trading at $12.06, up 10.04%, as biotech stocks rally.

  • The biotech sector is up 2.55%, alongside stronger major indexes.
  • No clear company-specific catalyst directly explains the September 17 move; Gossamer Bio’s board appointment announcement is supportive background, not an established cause.
  • The move appears primarily sector-driven, reflecting improving risk appetite after recent rate-related volatility.